Prostatic Neoplasms

"Prostatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the PROSTATE.

Descriptor ID	D011471
MeSH Number(s)	C04.588.945.440.770 C12.294.260.750 C12.294.565.625 C12.758.409.750
Concept/Terms	Prostatic Neoplasms Prostatic Neoplasms Prostate Neoplasms Neoplasms, Prostate Neoplasm, Prostate Prostate Neoplasm Neoplasms, Prostatic Neoplasm, Prostatic Prostatic Neoplasm Prostate Cancer Prostate Cancer Cancer, Prostate Cancers, Prostate Prostate Cancers Cancer of the Prostate Prostatic Cancer Cancer, Prostatic Cancers, Prostatic Prostatic Cancers Cancer of Prostate

Below are MeSH descriptors whose meaning is more general than "Prostatic Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Urogenital Neoplasms [C04.588.945]
Genital Neoplasms, Male [C04.588.945.440]
Prostatic Neoplasms [C04.588.945.440.770]
Male Urogenital Diseases [C12]
Genital Diseases, Male [C12.294]
Genital Neoplasms, Male [C12.294.260]
Prostatic Neoplasms [C12.294.260.750]
Prostatic Diseases [C12.294.565]
Prostatic Neoplasms [C12.294.565.625]
Urogenital Neoplasms [C12.758]
Genital Neoplasms, Male [C12.758.409]
Prostatic Neoplasms [C12.758.409.750]

Below are MeSH descriptors whose meaning is related to "Prostatic Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Prostatic Neoplasms".

Prostatic Neoplasms
Prostatic Neoplasms, Castration-Resistant

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Prostatic Neoplasms" by people in this website by year, and whether "Prostatic Neoplasms" was a major or minor topic of these publications.

Bar chart showing 272 publications over 25 distinct years, with a maximum of 19 publications in 2004

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
1996	3	0	3
1998	4	0	4
2000	4	0	4
2001	6	0	6
2002	13	1	14
2003	7	3	10
2004	15	4	19
2005	14	0	14
2006	8	2	10
2007	11	1	12
2008	14	1	15
2009	8	2	10
2010	10	1	11
2011	14	1	15
2012	12	0	12
2013	10	1	11
2014	13	3	16
2015	10	6	16
2016	14	2	16
2017	12	3	15
2018	9	0	9
2019	7	2	9
2020	17	0	17
2021	3	0	3

Below are the most recent publications written about "Prostatic Neoplasms" by people in Profiles.

Baltz JO, Vatanchi M, Jellinek NJ. Retronychia Triggered by Docetaxel. Dermatol Surg. 2021 06 01; 47(6):884-885.

View in: PubMed
Rosellini M, Santoni M, Mollica V, Rizzo A, Cimadamore A, Scarpelli M, Storti N, Battelli N, Montironi R, Massari F. Treating Prostate Cancer by Antibody-Drug Conjugates. Int J Mol Sci. 2021 Feb 04; 22(4).

View in: PubMed
Berry DL, Hong F, Blonquist TM, Halpenny B, Xiong N, Filson CP, Master VA, Sanda MG, Chang P, Chien GW, Jones RA, Krupski TL, Wolpin S, Wilson L, Hayes JH, Trinh QD, Sokoloff M. Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial. Urol Oncol. 2021 08; 39(8):493.e9-493.e15.

View in: PubMed
Aurilio G, Cimadamore A, Mazzucchelli R, Lopez-Beltran A, Verri E, Scarpelli M, Massari F, Cheng L, Santoni M, Montironi R. Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications. Cells. 2020 12 10; 9(12).

View in: PubMed
Frendl DM, FitzGerald G, Epstein MM, Allison JJ, Sokoloff MH, Ware JE. Predicting the 10-year risk of death from other causes in men with localized prostate cancer using patient-reported factors: Development of a tool. PLoS One. 2020; 15(12):e0240039.

View in: PubMed
Sohlberg EM, Thomas IC, Yang J, Kapphahn K, Velaer KN, Goldstein MK, Wagner TH, Chertow GM, Brooks JD, Patel CJ, Desai M, Leppert JT. Laboratory-wide association study of survival with prostate cancer. Cancer. 2021 04 01; 127(7):1102-1113.

View in: PubMed
Johnson JA, Moser RP, Ellison GL, Martin DN. Associations of Prostate-Specific Antigen (PSA) Testing in the US Population: Results from a National Cross-Sectional Survey. J Community Health. 2021 04; 46(2):389-398.

View in: PubMed
Rizzo A, Mollica V, Cimadamore A, Santoni M, Scarpelli M, Giunchi F, Cheng L, Lopez-Beltran A, Fiorentino M, Montironi R, Massari F. Is There a Role for Immunotherapy in Prostate Cancer? Cells. 2020 09 08; 9(9).

View in: PubMed
Sohlberg EM, Thomas IC, Yang J, Kapphahn K, Daskivich TJ, Skolarus TA, Shelton JB, Makarov DV, Bergman J, Bang CK, Goldstein MK, Wagner TH, Brooks JD, Desai M, Leppert JT. Life expectancy estimates for patients diagnosed with prostate cancer in the Veterans Health Administration. Urol Oncol. 2020 09; 38(9):734.e1-734.e10.

View in: PubMed
Lau HD, Clark M. Metastatic squamous cell carcinoma transformed from prostatic adenocarcinoma following androgen deprivation therapy: A case report with clinicopathologic and molecular findings. Diagn Cytopathol. 2020 Dec; 48(12):E14-E17.

View in: PubMed

People

Explore

Similar Concepts

Top Journals